Exosome Inhibiting Agents And Uses Thereof


Ontology type: sgo:Patent     


Patent Info

DATE

N/A

AUTHORS

WULF, Gerald

ABSTRACT

The invention relates to methods and compositions for reducing exosome mediated tumor resistance against a therapeutic binding molecule and for increasing the efficacy of a therapeutic binding molecule suitable in the treatment of a disease. The methods include administering an effective amount of at least one agent inhibiting exosome formation and administering the therapeutic binding molecule. More... »

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/3142", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "name": "WULF, Gerald", 
        "type": "Person"
      }
    ], 
    "citation": [
      {
        "id": "sg:pub.10.1038/nm0598-594", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1001835763", 
          "https://doi.org/10.1038/nm0598-594"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/0022-1759(86)90368-6", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1005054441"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/nri2567", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1008772299", 
          "https://doi.org/10.1038/nri2567"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1200/jco.2010.32.2321", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1011202679"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1172/jci40483", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1016830233"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1261/rna.2192803", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1021836441"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1073/pnas.0400067101", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1024245226"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1182/blood-2004-05-1733", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1026647477"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1083/jcb.200509022", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1027587030"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1158/1078-0432.ccr-05-2587", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1027920199"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1074/jbc.m507515200", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1031396757"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1002/ijc.2910240509", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1031502760"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1111/j.1600-0854.2004.00257.x", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1032440634"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/leu.2008.103", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1032542633", 
          "https://doi.org/10.1038/leu.2008.103"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.transproceed.2007.11.072", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1033712981"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1186/1479-5876-3-10", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1033807595", 
          "https://doi.org/10.1186/1479-5876-3-10"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1158/0008-5472.can-3263-2", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1040958236"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1165/rcmb.2003-0238oc", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1041194535"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1074/jbc.m110.134775", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1042696117"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/icb.2010.64", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1045713102", 
          "https://doi.org/10.1038/icb.2010.64"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/0022-1759(90)90358-3", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1046296525"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1055/s-0029-1241859", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1057208057"
        ], 
        "type": "CreativeWork"
      }
    ], 
    "description": "

The invention relates to methods and compositions for reducing exosome mediated tumor resistance against a therapeutic binding molecule and for increasing the efficacy of a therapeutic binding molecule suitable in the treatment of a disease. The methods include administering an effective amount of at least one agent inhibiting exosome formation and administering the therapeutic binding molecule.

", "id": "sg:patent.WO-2013014255-A1", "keywords": [ "exosomes", "invention", "method", "composition", "tumor resistance", "binding molecule", "efficacy", "disease", "agent" ], "name": "EXOSOME INHIBITING AGENTS AND USES THEREOF", "recipient": [ { "id": "https://www.grid.ac/institutes/grid.7450.6", "type": "Organization" } ], "sameAs": [ "https://app.dimensions.ai/details/patent/WO-2013014255-A1" ], "sdDataset": "patents", "sdDatePublished": "2019-03-07T15:35", "sdLicense": "https://scigraph.springernature.com/explorer/license/", "sdPublisher": { "name": "Springer Nature - SN SciGraph project", "type": "Organization" }, "sdSource": "s3://com.uberresearch.data.dev.patents-pipeline/full_run_10/sn-export/5eb3e5a348d7f117b22cc85fb0b02730/0000100128-0000348334/json_export_b670b59c.jsonl", "type": "Patent" } ]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/patent.WO-2013014255-A1'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/patent.WO-2013014255-A1'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/patent.WO-2013014255-A1'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/patent.WO-2013014255-A1'


 

This table displays all metadata directly associated to this object as RDF triples.

101 TRIPLES      14 PREDICATES      44 URIs      16 LITERALS      2 BLANK NODES

Subject Predicate Object
1 sg:patent.WO-2013014255-A1 schema:about anzsrc-for:3142
2 schema:author N8bbbcd495bde4f2993320cf10ebc1367
3 schema:citation sg:pub.10.1038/icb.2010.64
4 sg:pub.10.1038/leu.2008.103
5 sg:pub.10.1038/nm0598-594
6 sg:pub.10.1038/nri2567
7 sg:pub.10.1186/1479-5876-3-10
8 https://doi.org/10.1002/ijc.2910240509
9 https://doi.org/10.1016/0022-1759(86)90368-6
10 https://doi.org/10.1016/0022-1759(90)90358-3
11 https://doi.org/10.1016/j.transproceed.2007.11.072
12 https://doi.org/10.1055/s-0029-1241859
13 https://doi.org/10.1073/pnas.0400067101
14 https://doi.org/10.1074/jbc.m110.134775
15 https://doi.org/10.1074/jbc.m507515200
16 https://doi.org/10.1083/jcb.200509022
17 https://doi.org/10.1111/j.1600-0854.2004.00257.x
18 https://doi.org/10.1158/0008-5472.can-3263-2
19 https://doi.org/10.1158/1078-0432.ccr-05-2587
20 https://doi.org/10.1165/rcmb.2003-0238oc
21 https://doi.org/10.1172/jci40483
22 https://doi.org/10.1182/blood-2004-05-1733
23 https://doi.org/10.1200/jco.2010.32.2321
24 https://doi.org/10.1261/rna.2192803
25 schema:description <p>The invention relates to methods and compositions for reducing exosome mediated tumor resistance against a therapeutic binding molecule and for increasing the efficacy of a therapeutic binding molecule suitable in the treatment of a disease. The methods include administering an effective amount of at least one agent inhibiting exosome formation and administering the therapeutic binding molecule.</p>
26 schema:keywords agent
27 binding molecule
28 composition
29 disease
30 efficacy
31 exosomes
32 invention
33 method
34 tumor resistance
35 schema:name EXOSOME INHIBITING AGENTS AND USES THEREOF
36 schema:recipient https://www.grid.ac/institutes/grid.7450.6
37 schema:sameAs https://app.dimensions.ai/details/patent/WO-2013014255-A1
38 schema:sdDatePublished 2019-03-07T15:35
39 schema:sdLicense https://scigraph.springernature.com/explorer/license/
40 schema:sdPublisher N65b748ea958540b3a439407b08327e90
41 sgo:license sg:explorer/license/
42 sgo:sdDataset patents
43 rdf:type sgo:Patent
44 N65b748ea958540b3a439407b08327e90 schema:name Springer Nature - SN SciGraph project
45 rdf:type schema:Organization
46 N8bbbcd495bde4f2993320cf10ebc1367 rdf:first Nd6198c5536004b05939f82d25bb895a1
47 rdf:rest rdf:nil
48 Nd6198c5536004b05939f82d25bb895a1 schema:name WULF, Gerald
49 rdf:type schema:Person
50 anzsrc-for:3142 schema:inDefinedTermSet anzsrc-for:
51 rdf:type schema:DefinedTerm
52 sg:pub.10.1038/icb.2010.64 schema:sameAs https://app.dimensions.ai/details/publication/pub.1045713102
53 https://doi.org/10.1038/icb.2010.64
54 rdf:type schema:CreativeWork
55 sg:pub.10.1038/leu.2008.103 schema:sameAs https://app.dimensions.ai/details/publication/pub.1032542633
56 https://doi.org/10.1038/leu.2008.103
57 rdf:type schema:CreativeWork
58 sg:pub.10.1038/nm0598-594 schema:sameAs https://app.dimensions.ai/details/publication/pub.1001835763
59 https://doi.org/10.1038/nm0598-594
60 rdf:type schema:CreativeWork
61 sg:pub.10.1038/nri2567 schema:sameAs https://app.dimensions.ai/details/publication/pub.1008772299
62 https://doi.org/10.1038/nri2567
63 rdf:type schema:CreativeWork
64 sg:pub.10.1186/1479-5876-3-10 schema:sameAs https://app.dimensions.ai/details/publication/pub.1033807595
65 https://doi.org/10.1186/1479-5876-3-10
66 rdf:type schema:CreativeWork
67 https://doi.org/10.1002/ijc.2910240509 schema:sameAs https://app.dimensions.ai/details/publication/pub.1031502760
68 rdf:type schema:CreativeWork
69 https://doi.org/10.1016/0022-1759(86)90368-6 schema:sameAs https://app.dimensions.ai/details/publication/pub.1005054441
70 rdf:type schema:CreativeWork
71 https://doi.org/10.1016/0022-1759(90)90358-3 schema:sameAs https://app.dimensions.ai/details/publication/pub.1046296525
72 rdf:type schema:CreativeWork
73 https://doi.org/10.1016/j.transproceed.2007.11.072 schema:sameAs https://app.dimensions.ai/details/publication/pub.1033712981
74 rdf:type schema:CreativeWork
75 https://doi.org/10.1055/s-0029-1241859 schema:sameAs https://app.dimensions.ai/details/publication/pub.1057208057
76 rdf:type schema:CreativeWork
77 https://doi.org/10.1073/pnas.0400067101 schema:sameAs https://app.dimensions.ai/details/publication/pub.1024245226
78 rdf:type schema:CreativeWork
79 https://doi.org/10.1074/jbc.m110.134775 schema:sameAs https://app.dimensions.ai/details/publication/pub.1042696117
80 rdf:type schema:CreativeWork
81 https://doi.org/10.1074/jbc.m507515200 schema:sameAs https://app.dimensions.ai/details/publication/pub.1031396757
82 rdf:type schema:CreativeWork
83 https://doi.org/10.1083/jcb.200509022 schema:sameAs https://app.dimensions.ai/details/publication/pub.1027587030
84 rdf:type schema:CreativeWork
85 https://doi.org/10.1111/j.1600-0854.2004.00257.x schema:sameAs https://app.dimensions.ai/details/publication/pub.1032440634
86 rdf:type schema:CreativeWork
87 https://doi.org/10.1158/0008-5472.can-3263-2 schema:sameAs https://app.dimensions.ai/details/publication/pub.1040958236
88 rdf:type schema:CreativeWork
89 https://doi.org/10.1158/1078-0432.ccr-05-2587 schema:sameAs https://app.dimensions.ai/details/publication/pub.1027920199
90 rdf:type schema:CreativeWork
91 https://doi.org/10.1165/rcmb.2003-0238oc schema:sameAs https://app.dimensions.ai/details/publication/pub.1041194535
92 rdf:type schema:CreativeWork
93 https://doi.org/10.1172/jci40483 schema:sameAs https://app.dimensions.ai/details/publication/pub.1016830233
94 rdf:type schema:CreativeWork
95 https://doi.org/10.1182/blood-2004-05-1733 schema:sameAs https://app.dimensions.ai/details/publication/pub.1026647477
96 rdf:type schema:CreativeWork
97 https://doi.org/10.1200/jco.2010.32.2321 schema:sameAs https://app.dimensions.ai/details/publication/pub.1011202679
98 rdf:type schema:CreativeWork
99 https://doi.org/10.1261/rna.2192803 schema:sameAs https://app.dimensions.ai/details/publication/pub.1021836441
100 rdf:type schema:CreativeWork
101 https://www.grid.ac/institutes/grid.7450.6 schema:Organization
 




Preview window. Press ESC to close (or click here)


...